Member Info for Owl11

https://twitter.com/AimInvestments/status/1378906057800511492?s=20

https://www.nih.gov/research-training/medical-research-initiatives/activ/covid-19-therapeutics-prioritized-testing-clinical-trials

Updated on the 2nd April.

https://youtu.be/WXv8nBUdUSg

SNG at 40mins 30secs.

https://www.20minutes.fr/sante/3008871-20210329-coronavirus-hauts-france-comment-traitement-prometteur-contre-covid-pu-faire-croire-efficacite-hydroxychloroquine

There's going to be some nerves when that RNS finally lands, that's for sure.

https://twitter.com/MARYau_MCU_PH/status/1373573401839828993?s=20

Not sure if already posted as 3 days old.

http://www.hautsdefrance.fr/covid-19-les-hauts-de-france-sur-la-bonne-voie-du-medicament/

Sorry my post was for AJB thread.

Same here, keep an eye on it but imagine it will resolve itself soon.

https://bisouv.com/uncategorized/3186585/interferon-market-to-see-huge-growth-by-2026-novartis-novo-nordisk-merck/

No option to translate, perhaps someone can and summarise.
https://nerdswire.de/covid-19-patienten-haben-6-monate-spaeter-immer-noch-symptome-interferon-kann-schliesslich-eine-hilfreiche-behandlung-sein/

Absolutely Mike, that's the reason I posted the link, the tweet was today. Clearly happy for attention to be drawn towards SNG.

https://www.trendsmap.com/twitter/tweet/1370676008144175109

Two other complementary projects also selected
Two other nationally labeled research projects are adjacent to “COV-NI”. In Bordeaux, “COVERAGE” is also trying to assess the effectiveness of several inhalation treatments (on patients over 65 years of age on an outpatient basis) including interferon, while the “SPRINTER” project (led by the company British Synairgen) is also studying the effectiveness of inhaled interferon-beta (for 14 days). “ Synairgen has already noted 80% fewer intubated patients, which is already a reassuring indication. But it is necessary to confirm because this observation is compatible with an effect which can range from a real reduction of 7 to 96% ”, comments Doctor Aurélien Mary.

https://premium.courrier-picard.fr/id172882/article/2021-03-11/chu-damiens-un-essai-de-traitement-contre-le-covid-19-labellise-priorite

Sng at the end in the shaded box (might have to register)

https://www.nytimes.com/interactive/2020/science/coronavirus-drugs-treatments.html

https://www.ocregister.com/2021/02/28/coronavirus-vaccines-overshadow-furious-effort-to-find-new-treatments

This could be significant if it is us, the French health minister isnt going to risk losing face by discussing something which isnt showing real potential.

https://www.pharmiweb.com/press-release/2021-02-22/aerosol-delivery-devices-market-size-to-reach-usd-4672-billion-globally-by-2027

https://www.google.co.uk/url?sa=t&source=web&rct=j&url=https://www.nih.gov/activ/nih-funded-activ/activ-associated-clinical-trials&ved=2ahUKEwiimK2J0_ruAhVNSsAKHVlZB4Q4ChAWMAB6BAgJEAI&usg=AOvVaw3qlUMFvtDVsKQgSabARBQI